131 related articles for article (PubMed ID: 25939445)
1. Glanzmann's thrombasthenia: meeting the anticoagulation challenge.
Binder A; Aledort L
Haemophilia; 2015 Jul; 21(4):e322-3. PubMed ID: 25939445
[No Abstract] [Full Text] [Related]
2. Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy.
Gunaydin B; Ozkose Z; Pezek S
J Anesth; 2007; 21(1):106-7. PubMed ID: 17285428
[No Abstract] [Full Text] [Related]
3. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
Javed A; Ayyub M; Abrar S; Mansoor M; Khan B; Hussain T
J Ayub Med Coll Abbottabad; 2009; 21(2):171-3. PubMed ID: 20524499
[TBL] [Abstract][Full Text] [Related]
4. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
Kale A; Bayhan G; Yalinkaya A; Yayla M
J Perinat Med; 2004; 32(5):456-8. PubMed ID: 15493726
[TBL] [Abstract][Full Text] [Related]
5. Treatment of spontaneous intracerebral haemorrhage in Glanzmann's thrombasthenia.
Vigren P; Ström JO; Petrini P; Callander M; Theodorsson A
Haemophilia; 2012 Sep; 18(5):e381-3. PubMed ID: 22765655
[No Abstract] [Full Text] [Related]
6. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
Franchini M; Lippi G
Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
[TBL] [Abstract][Full Text] [Related]
7. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.
Erduran E; Aksoy A; Zaman D
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):215-7. PubMed ID: 19657319
[TBL] [Abstract][Full Text] [Related]
8. Pattern of bleeding and response to therapy in Glanzmann thrombasthenia.
Borhany M; Fatima H; Naz A; Patel H; Shamsi T
Haemophilia; 2012 Nov; 18(6):e423-5. PubMed ID: 22970800
[No Abstract] [Full Text] [Related]
9. Management of persistent gastric bleeding in a patient with Glanzmann's thrombasthenia.
Bakdash S; Lyons JM; Bastacky SI; Pezzone MA; McGee JB; Schoen RE; Regueiro M; Lee KK; Bontempo FA
Am J Hematol; 2008 May; 83(5):411-5. PubMed ID: 18186523
[No Abstract] [Full Text] [Related]
10. Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.
Recht M; Rajpurkar M; Chitlur M; d'Oiron R; Zotz R; Di Minno G; Cooper DL; Poon MC
Am J Hematol; 2017 Jul; 92(7):646-652. PubMed ID: 28370369
[TBL] [Abstract][Full Text] [Related]
11. Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.
Di Minno G; Coppola A; Di Minno MN; Poon MC
Thromb Haemost; 2009 Dec; 102(6):1157-64. PubMed ID: 19967146
[TBL] [Abstract][Full Text] [Related]
12. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
Poon MC; d'Oiron R; Zotz RB; Bindslev N; Di Minno MN; Di Minno G;
Haematologica; 2015 Aug; 100(8):1038-44. PubMed ID: 26001792
[TBL] [Abstract][Full Text] [Related]
13. Glanzmann's thrombasthenia proposed optimal management during surgery and delivery.
Bell JA; Savidge GF
Clin Appl Thromb Hemost; 2003 Apr; 9(2):167-70. PubMed ID: 12812388
[TBL] [Abstract][Full Text] [Related]
14. Perioperative management of Glanzmann's syndrome: how we did it!
Depner C; Schmid R; Kirchhoff P; Oertli D
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):283-4. PubMed ID: 20182353
[TBL] [Abstract][Full Text] [Related]
15. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant factor VIIa for post-operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodies.
Patel RK; Savidge GF; Rangarajan S
Br J Haematol; 2001 Jul; 114(1):245-6. PubMed ID: 11472380
[No Abstract] [Full Text] [Related]
17. Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia.
Kadowaki S; Makino S; Mohri Y; Awaguni H; Shinozuka J; Imashuku S
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):155-158. PubMed ID: 33196513
[TBL] [Abstract][Full Text] [Related]
18. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa.
Conte R; Cirillo D; Ricci F; Tassi C; Tazzari PL
Haematologica; 1997; 82(1):73-4. PubMed ID: 9107089
[TBL] [Abstract][Full Text] [Related]
19. Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy.
Duman EN; Saylan S; Cekic B
Rev Bras Anestesiol; 2012 Jul; 62(4):548-53. PubMed ID: 22793971
[TBL] [Abstract][Full Text] [Related]
20. Thromboelastographic evaluation of recombinant factor VIIa in a child with Glanzmann's thrombasthenia.
Ismael F; van der Meer J; de Wolf JT; Kuizenga K; Aarts LP; Hendriks HG
Anesth Analg; 2006 Sep; 103(3):791-2. PubMed ID: 16931713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
